Novo Nordisk flags Cagrilintide promise in hunt for next obesity drug
The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy…
Novo Nordisk’s Martin Holst Lange previews obesity pill
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news…
Eli Lilly’s Daniel Skovronsky talks obesity pill data
The Eli Lilly headquarters in Indianapolis, Indiana, on Aug. 15, 2024. AJ Mast | Bloomberg | Getty Images…
Rocket Pharma’s shares soar after US FDA lets gene therapy trial resume
Rafael Henrique | SOPA Images | AP The U.S. health regulator has allowed a study of Rocket Pharmaceuticals’…
Novo Nordisk offers diabetes drug Ozempic for steep cash discount
A box of Ozempic made by Novo Nordisk, at a pharmacy in London on March 8, 2024. Hollie…
Eli Lilly hikes price of Mounjaro in UK amid Trump pressure
Mounjaro manufactured by Eli Lilly and Company packaging is seen in this illustration photo taken in a pharmacy…
Eli Lilly obesity pill orforglipron led to 12% weight loss
Eli Lilly on Thursday said the highest dose of its daily obesity pill helped patients lose almost 12%…
Eli Lilly (LLY) Q2 2025 earnings report
The Eli Lilly logo is shown on one of the company’s offices in San Diego, California, on Sept.…
Eli Lilly earnings are coming Thursday. What top analysts expect
Many on Wall Street expect that Novo Nordisk ‘s loss has been Eli Lilly ‘s gain, and this…
UnitedHealth Group (UNH) earnings report Q2 2025
UnitedHealth Group on Tuesday issued a 2025 outlook that fell short of Wall Street’s expectations, as the company’s…
Sarepta resumes shipping of gene therapy Elevidys to patients who can walk
A sign marks the offices of Sarepta Therapeutics in Cambridge, Massachusetts, U.S., July 22, 2025. Brian Snyder |…
Researchers move closer to a universal cancer vaccine
Wildpixel | Istock | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter,…